Post-surgical Pain Treatment Market The post-surgical pain pipeline features several potential drugs in mid and late-stage development that are expected to be approved in the near future. Major pharmaceutical and biotech companies, such as Vivozon Inc., PainReform LTD, and Nevakar, Inc., are poised to create a significant positive impact on the post-surgical pain treatment landscape […]
July 15, 2024 – In an unprecedented surge, Trump Media & Technology Group (NASDAQ: DJT) saw its stock price skyrocket in pre-market trading today, following news of an assassination attempt on former President Donald Trump. The attempted attack, which occurred late last night, has not only brought a wave of sympathy but also renewed investor interest […]
DelveInsight’s, “Gastrointestinal Stromal Tumors Pipeline Insight 2024” report provides comprehensive insights about 25+ companies and 28+ pipeline drugs in Gastrointestinal Stromal Tumors (GIST) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Anti-CD19 Antibody pipeline constitutes key companies continuously working towards developing Anti-CD19 Antibody treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Anti-CD19 Antibody Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development […]
Key players in the empty capsules market include Capsugel (Lonza) (Switzerland), ACG (India), QUALICAPS (Roquette Frères) (France), SUHEUNG (South Korea), Shanxi Guangsheng Capsule Limited (China), CapsCanada (Lyfe Group) (US) Browse 356 market data Tables and 48 Figures spread through 333 Pages and in-depth TOC on “Empty Capsules Market by Type (Gelatin (Porcine, Bovine, Bonemeal), Non-gelatin […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, ANCA Vasculitis pipeline constitutes 12+ key companies continuously working towards developing 12+ ANCA Vasculitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “ANCA Vasculitis Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Sepsis pipeline constitutes 25+ key companies continuously working towards developing 30+ Sepsis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Sepsis Pipeline Insight, 2024“ report by DelveInsight outlines comprehensive insights into the present clinical development scenario […]
(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Diffuse Large B-cell Lymphoma pipeline constitutes 70+ key companies continuously working towards developing 75+ Diffuse Large B-cell Lymphoma treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Diffuse Large B-cell Lymphoma Pipeline Insight, 2024“ report by DelveInsight […]
DelveInsight’s, “Melanoma Pipeline Insight 2024” report provides comprehensive insights about 150+ companies and 170+ pipeline drugs in Melanoma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. […]
DelveInsight, “Major Depressive Disorder Pipeline Insight 2024” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Major Depressive Disorder pipeline landscape. It covers the Major Depressive Disorder pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Major Depressive Disorder pipeline therapeutics assessment by product type, stage, route […]
